作者: Fariba Seyedoshohadaei , Laleh Tangestani , Farnaz Zandvakili , Naser Rashadmanesh
DOI: 10.7860/JCDR/2016/20954.8324
关键词:
摘要: Introduction Clomiphene citrate is the first-line therapy for ovulation induction in Polycystic Ovarian Syndrome (PCOS). This drug binds and blocks estrogen receptors thought to have an anti estrogenic effect on endometrium volume, thus may adverse fertility.